| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.18 | 0.004 |